CHMP recommends approval of 6-in-1 pediatric vaccine
This article was originally published in Scrip
Executive Summary
Expert reviewers on the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) have recommended approval for the six-in-one pediatric vaccine Hexyon/Hexacima from Sanofi Pasteur, the vaccines division of Sanofi. The vaccine will be commercialized under the Hexyon brand name in Western Europe by Sanofi Pasteur MSD, a joint venture beween Sanofi Pasteur and Merck & Co's Merck Sharp & Dohme, and as Hexacima in Eastern Europe by Sanofi Pasteur on its own.